Meta Information

ID:nebivolol

Name:Nebivolol

Schema Version:1.5

Alternate Names

• Bystolic
• Brevibloc

Intervention Type

therapeutic_agent

Expected Cost Mean

Low Cost:

10

High Cost:

50

Cost Type:

monthly

Description:

Generic nebivolol is affordable; often covered by insurance for hypertension.

Summary

Nebivolol is a beta-1 selective adrenergic blocker with unique nitric oxide-mediated vasodilatory properties. This dual action improves endothelial function and reduces arterial stiffness, potentially mitigating age-related cardiovascular decline beyond simple blood pressure reduction. Its ability to enhance NO bioavailability is a key differentiator among beta-blockers, offering a mechanism relevant to vascular aging.

Purpose

Beta-blocker improving endothelial function, reducing arterial stiffness for cardiovascular health.

Card Summary

Beta-1 selective blocker with nitric oxide-mediated vasodilation, improving endothelial function and reducing arterial stiffness.

Drug Class

Beta-blockers

Drugs In Class

Empty Array

Impact

Score:

7.2

Justification:

Improves endothelial function, reduces arterial stiffness, robust cardiovascular benefits.

Evidence

Grade:

A

Score:

8.5

Justification:

Extensive human RCTs confirm efficacy for hypertension and heart failure.

Safety

Score:

5.5

Justification:

Regulated pharmaceutical with common, manageable side effects.

Flags

• Common side effects include fatigue, bradycardia, dizziness, and sexual dysfunction.
• Abrupt discontinuation can lead to withdrawal syndrome, including angina or myocardial infarction.
• Contraindicated in severe bradycardia, heart block, cardiogenic shock, or decompensated heart failure.
• May mask symptoms of hypoglycemia in diabetic patients.
• Interacts with other antihypertensives, NSAIDs, and CYP2D6 inhibitors.

Verdict

Improves cardiovascular health; consult physician for appropriate use.

Model

Gemini 3 Flash

Delivery

Route:

oral

Scope:

• systemic

Indication

Focus:

healthspan

Description:

Nebivolol is a beta-1 selective adrenergic blocker with unique nitric oxide-mediated vasodilatory properties. This dual action improves endothelial function and reduces arterial stiffness, potentially...

Typical Protocol

• Typically prescribed 5-40 mg daily for hypertension; healthspan interest lies in its endothelial benefits at potentially lower doses, off-label.